023910.KQ
Daihan Pharmaceutical Co.,Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 27,250.00
+1.49%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 5.89x
- P/E 2027E
- 5.56x
- P/E 2028E
- 5.26x
- P/S forward
- 1.42x
Trailing multiples
Trailing twelve months
- P/E TTM
- 5.82x
- PEG TTM
- 0.57x
- Price / book
- 0.52x
- Price / sales
- 0.74x
- Price / cash flow
- 4.29x
Enterprise value
- Enterprise value
- KRW 45.5B
- EV / sales
- 0.21x
- EV / EBITDA
- 1.05x
- EV / EBIT
- 1.51x
- Market cap
- KRW 160.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026